seed
Stage
2014
Founded
1
Investors
About
Spero Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines for immune-mediated diseases and rare infections, including investigational therapies such as SP001 for IgG4-related disease and tebipenem pivoxil for complicated urinary tract infections.
Explore Spero Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.